118 related articles for article (PubMed ID: 30320629)
21. The Prognostic and Predictive Value of Melanoma-related MicroRNAs Using Tissue and Serum: A MicroRNA Expression Analysis.
Stark MS; Klein K; Weide B; Haydu LE; Pflugfelder A; Tang YH; Palmer JM; Whiteman DC; Scolyer RA; Mann GJ; Thompson JF; Long GV; Barbour AP; Soyer HP; Garbe C; Herington A; Pollock PM; Hayward NK
EBioMedicine; 2015 Jul; 2(7):671-80. PubMed ID: 26288839
[TBL] [Abstract][Full Text] [Related]
22. Pivotal MicroRNAs in Melanoma: A Mini-Review.
Deng Z; Hao J; Lei D; He Y; Lu L; He L
Mol Diagn Ther; 2016 Oct; 20(5):449-55. PubMed ID: 27351922
[TBL] [Abstract][Full Text] [Related]
23. Signatures of microRNAs and selected microRNA target genes in human melanoma.
Philippidou D; Schmitt M; Moser D; Margue C; Nazarov PV; Muller A; Vallar L; Nashan D; Behrmann I; Kreis S
Cancer Res; 2010 May; 70(10):4163-73. PubMed ID: 20442294
[TBL] [Abstract][Full Text] [Related]
24. microRNA expression in tumour tissue and plasma in patients with newly diagnosed metastatic prostate cancer.
Zedan AH; Hansen TF; Assenholt J; Pleckaitis M; Madsen JS; Osther PJS
Tumour Biol; 2018 May; 40(5):1010428318775864. PubMed ID: 29775158
[TBL] [Abstract][Full Text] [Related]
25. Expression of miR-203 is decreased and associated with the prognosis of melanoma patients.
Wang K; Zhang ZW
Int J Clin Exp Pathol; 2015; 8(10):13249-54. PubMed ID: 26722525
[TBL] [Abstract][Full Text] [Related]
26. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.
Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG
Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773
[TBL] [Abstract][Full Text] [Related]
27. A miRNA-Based Signature Detected in Primary Melanoma Tissue Predicts Development of Brain Metastasis.
Hanniford D; Zhong J; Koetz L; Gaziel-Sovran A; Lackaye DJ; Shang S; Pavlick A; Shapiro R; Berman R; Darvishian F; Shao Y; Osman I; Hernando E
Clin Cancer Res; 2015 Nov; 21(21):4903-12. PubMed ID: 26089374
[TBL] [Abstract][Full Text] [Related]
28. Early Circulating Tumour DNA Variations Predict Tumour Response in Melanoma Patients Treated with Immunotherapy.
Keller L; Guibert N; Casanova A; Brayer S; Farella M; Delaunay M; Gilhodes J; Martin E; Balagué G; Favre G; Pradines A; Meyer N
Acta Derm Venereol; 2019 Feb; 99(2):206-210. PubMed ID: 30393817
[TBL] [Abstract][Full Text] [Related]
29. Circulating epigenetic biomarkers in melanoma.
Xin Y; Li Z; Chan MT; Wu WK
Tumour Biol; 2016 Feb; 37(2):1487-92. PubMed ID: 26662802
[TBL] [Abstract][Full Text] [Related]
30. BRAF mutation testing in melanoma: results from a German observational multicenter study.
Hartmann A; Schirmacher P; Sterlacci W; Koch W; Liesenfeld DB; Schif B; Garbe C
Virchows Arch; 2019 Jan; 474(1):71-78. PubMed ID: 30406424
[TBL] [Abstract][Full Text] [Related]
31. Targeting of TRX2 by miR-330-3p in melanoma inhibits proliferation.
Yao Y; Zuo J; Wei Y
Biomed Pharmacother; 2018 Nov; 107():1020-1029. PubMed ID: 30257313
[TBL] [Abstract][Full Text] [Related]
32. Determination of prognosis in metastatic melanoma through integration of clinico-pathologic, mutation, mRNA, microRNA, and protein information.
Jayawardana K; Schramm SJ; Haydu L; Thompson JF; Scolyer RA; Mann GJ; Müller S; Yang JY
Int J Cancer; 2015 Feb; 136(4):863-74. PubMed ID: 24975271
[TBL] [Abstract][Full Text] [Related]
33. Disturbed protein-protein interaction networks in metastatic melanoma are associated with worse prognosis and increased functional mutation burden.
Schramm SJ; Li SS; Jayaswal V; Fung DC; Campain AE; Pang CN; Scolyer RA; Yang YH; Mann GJ; Wilkins MR
Pigment Cell Melanoma Res; 2013 Sep; 26(5):708-22. PubMed ID: 23738911
[TBL] [Abstract][Full Text] [Related]
34. Expression and clinicopathological significance of microRNA-21 and programmed cell death 4 in malignant melanoma.
Jiao J; Fan Y; Zhang Y
J Int Med Res; 2015 Oct; 43(5):672-8. PubMed ID: 26150475
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA and mRNA expression profiling in metastatic melanoma reveal associations with BRAF mutation and patient prognosis.
Tembe V; Schramm SJ; Stark MS; Patrick E; Jayaswal V; Tang YH; Barbour A; Hayward NK; Thompson JF; Scolyer RA; Yang YH; Mann GJ
Pigment Cell Melanoma Res; 2015 May; 28(3):254-66. PubMed ID: 25490969
[TBL] [Abstract][Full Text] [Related]
36. Differential BMI1, TWIST1, SNAI2 mRNA expression pattern correlation with malignancy type in a spectrum of common cutaneous malignancies: basal cell carcinoma, squamous cell carcinoma, and melanoma.
Vand-Rajabpour F; Sadeghipour N; Saee-Rad S; Fathi H; Noormohammadpour P; Yaseri M; Hesari KK; Bagherpour Z; Tabrizi M
Clin Transl Oncol; 2017 Apr; 19(4):489-497. PubMed ID: 27718152
[TBL] [Abstract][Full Text] [Related]
37. Elevated Levels of SOX10 in Serum from Vitiligo and Melanoma Patients, Analyzed by Proximity Ligation Assay.
Blokzijl A; Chen LE; Gustafsdottir SM; Vuu J; Ullenhag G; Kämpe O; Landegren U; Kamali-Moghaddam M; Hedstrand H
PLoS One; 2016; 11(4):e0154214. PubMed ID: 27110718
[TBL] [Abstract][Full Text] [Related]
38. IL-10Rα expression is post-transcriptionally regulated by miR-15a, miR-185, and miR-211 in melanoma.
Venza I; Visalli M; Beninati C; Benfatto S; Teti D; Venza M
BMC Med Genomics; 2015 Dec; 8():81. PubMed ID: 26631117
[TBL] [Abstract][Full Text] [Related]
39. Circulating Tumour DNA for Monitoring Treatment Response to Anti-PD-1 Immunotherapy in Melanoma Patients.
Ashida A; Sakaizawa K; Uhara H; Okuyama R
Acta Derm Venereol; 2017 Nov; 97(10):1212-1218. PubMed ID: 28681063
[TBL] [Abstract][Full Text] [Related]
40. Illustrative cases for monitoring by quantitative analysis of BRAF/NRAS ctDNA mutations in liquid biopsies of metastatic melanoma patients who gained clinical benefits from anti-PD1 antibody therapy.
Seremet T; Planken S; Schreuer M; Jansen Y; Delaunoy M; El Housni H; Lienard D; Del Marmol V; Heimann P; Neyns B
Melanoma Res; 2018 Feb; 28(1):65-70. PubMed ID: 29227333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
